Catheter Precision, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Catheter Precision, Inc. (VTAK) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$26.86 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-03-28
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$8.16M.
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$4.76M.
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$8.45M.
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$5.50M.
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$26.86M.
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$27.26M.
- Catheter Precision, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$35.32M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$12.92M derived: sum of 2 quarters · filed 2023-03-28 | -$21.37M derived: sum of 3 quarters · filed 2023-03-28 | -$26.86M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$4.76M 10-Q · filed 2022-11-14 | -$13.21M derived: sum of 2 quarters · filed 2022-11-14 | -$18.71M 10-Q · filed 2022-11-14 | -$26.99M derived: sum of 4 quarters · filed 2023-03-28 |
| 2022-06-30 | -$8.45M 10-Q · filed 2022-08-16 | -$13.94M 10-Q · filed 2022-08-16 | -$22.23M derived: sum of 3 quarters · filed 2023-03-28 | -$29.61M derived: sum of 4 quarters · filed 2023-03-28 |
| 2022-03-31 | -$5.50M 10-Q · filed 2022-05-16 | -$13.78M derived: sum of 2 quarters · filed 2023-03-28 | -$21.16M derived: sum of 3 quarters · filed 2023-03-28 | -$25.88M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-12-31 | -$8.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$15.66M derived: sum of 2 quarters · filed 2023-03-28 | -$20.38M derived: sum of 3 quarters · filed 2023-03-28 | -$27.26M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$7.38M 10-Q · filed 2022-11-14 | -$12.10M derived: sum of 2 quarters · filed 2022-11-14 | -$18.97M 10-Q · filed 2022-11-14 | -$29.22M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$4.72M 10-Q · filed 2022-08-16 | -$11.60M 10-Q · filed 2022-08-16 | -$21.84M derived: sum of 3 quarters · filed 2022-08-16 | -$29.35M derived: sum of 4 quarters · filed 2022-08-16 |
| 2021-03-31 | -$6.88M 10-Q · filed 2022-05-16 | -$17.12M derived: sum of 2 quarters · filed 2022-05-16 | -$24.63M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$10.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$17.76M derived: sum of 2 quarters · filed 2022-03-24 | -$35.32M 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$7.51M 10-Q · filed 2021-11-15 | -$25.08M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |